Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | |
| Sales | 239 | 0 |
| Cost of Goods | 109 | N/A |
| Gross Profit | 130 | N/A |
| Operating Expenses | 3,790 | 0 |
| Operating Income | -3,551 | N/A |
| Other Income | 3,230 | 0 |
| Pre-tax Income | -321 | 0 |
| Net Income Continuous | -321 | N/A |
| Minority Interests | -86 | N/A |
| Net Income | $-235 | $N/A |
| EPS Basic Total Ops | -0.35 | N/A |
| EPS Basic Continuous Ops | -0.33 | N/A |
| EPS Diluted Total Ops | -0.35 | N/A |
| EPS Diluted Continuous Ops | -0.33 | N/A |
| EBITDA(a) | $-3,429 | $N/A |